How casuistry and virtue ethics might break the ideological stalemate troubling agricultural biotechnology

Business Ethics Quarterly

Volumn 12, Issue 3, 2002, Pages 305-330

  Calkins, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036327923     PISSN: 1052150X     EISSN: None     Source Type: Journal    
DOI: 10.5840/10.2307/3858019     Document Type: Article

References (86)

1. Getting down to cases: The revival of casuistry in bioethics
2. Biotech companies take on critics of gene-altered food
3. Monsanto and pharmacia to join, creating a pharmaceutical giant
4. Does business ethics rest on a mistake?
5. The green revolution: Peace and humanity
6. Business ethics, philosophy, and the next 25 years
7. Casuistry and the business case method
8. Adam Smith, Aristotle, and the virtues of commerce
9. Flourishing and the failure of the ethics of virtue
10. Ethical responsibilities of engineers in large organizations: The pinto case
11. Investors are wary of pharmacia merger
12. Pharmacia & upjohn, monsanto boards approve $27 billion merger of equals
13. And calls for openness and transparency
14. GM debate must go global, says meeting
15. The use of virtue and character in applied ethics
16. Environmentally correct since 1506
17. Friends of Al?
18. Technology (a special report): What's ahead for... tobacco
19. EPA gets stricter on altered corn to aid butterflies
20. Why Europe fears biotech foods
21. Biotech convention draws more visitors for 2001, as protestor numbers dwindle
22. The ford Pinto
23. Ecological eugenics
24. GM food 'dumped on India as aid
25. Govt gives monsanto biosafety clearance
26. Fun facts to know and tell about biotechnology
27. Casuistry as methodology in clinical ethics
28. Platonic insults: Casuistical
29. Casuistry: An alternative or complement to principles?
30. FDA signals tighter biofood oversight as pressure from opponents increases
31. Monsanto is sued over genetically altered crops
32. Once quick converts, farmers begin to lose faith in biotech crops
33. Biotech Ad campaign attempts to shape U.S. attitudes toward modified crops
34. U.S. farms to lift modified-seed use 10% this spring
35. Use of genetically modified seed by U.S. farmers increases 18%
36. Monsanto Boss's vision of 'life sciences' firm now confronts reality
37. For those fighting biotech crops, santa came early this year
38. Unveiling rules on genetic engineering, beijing embraces a controversial science
39. AstraZeneca and novartis near a deal
40. Bourgeois virtue
41. Toward an ethics of organizations
42. 130 Nations agree on safety rules for biotech food
43. Miracle worker
44. Novartis wins court ruling in europe on plant patents
45. Europe lifts patent embargo on transgenic plants and animals
46. Educated US public get more wary of genetic engineering
47. US tightens up on 'speculative' claims
48. Internal objections to virtue ethics
49. The moral psychology of business: Care and compassion in the corporation
50. Germany gets in a lather about altering beer genes
51. How a U.S. gadfly and a green activist started a food fight
52. Vatican experts ok plant, animal genetic engineering
53. The rashomon effect
54. Plasma international